Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Frontiers in Immunology(2022)
Key words
SARS-CoV-2 (COVID-19),mRNA vaccine,T-cell repertoire,inflammatory bowel disease,immunodeficiency
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined